216
P. Shejwalkar et al. / Inorganica Chimica Acta 366 (2011) 209–218
aromatic), 7.05ꢀ7.03 (m, 2H, aromatic), 4.87ꢀ4.83 (m, 4H, 2NCH2),
3.70ꢀ3.60 (m, 4H, 2NCH2); 13C{1H} NMR (CDCl3): d = 149.3 (s),
148.3 (s), 137.3 (s), 137.1 (s), 132.6 (s), 131.9 (s), 131.4 (s), 130.7
(s), 130.5 (s), 129.0 (s), 128.8 (s), 128.5 (s), 127.7 (s), 127.4 (s),
127.2 (s), 126.7 (s), 126.3 (s), 125.5 (s), 125.3 (s), 123.4 (s), 123.3
(s), 122.9 (s), 120.9 (s, aromatic), 50.0 (s, CH2); 31P{1H} NMR
1H NMR (CDCl3): d = 7.37ꢀ7.19 (m, 10H, aromatic), 7.04–7.03
(m, 4H, aromatic), 6.70ꢀ6.67 (m, 4H, aromatic), 5.54 (broad s,
2H, 2 = CH), 4.30–4.26 (m, 4H, 2NCH2), 3.92 (broad s, 2H, 2 = CH),
3.68 (s, 6H, 2CH3), 2.28–2.17 (m, 4H, 2CH2), 2.05ꢀ2.02 (m, 4H,
2CH2); 13C{1H} NMR (CDCl3): d = 156.4 (s), 146.4 (d, J = 8.6 Hz),
137.9 (s), 129.2 (s), 128.6 (s), 127.5 (s), 122.2 (d, J = 4.8 Hz), 114.6
(s), 111.3 (dd, J = 5.8, J = 15.4 Hz, @CH), 71.6 (dd, J = 1.1,
J = 13.3 Hz, @CH), 55.8 (s), 50.8 (d, J = 11.6 Hz), 33.2 (s), 28.7 (s);
1
(CDCl3): d = 142.1 (d, JPRh = 199 Hz).
1
4.2.12. [RhCl(COD){rac-(6)}], (rac)-13
31P{1H} NMR (CDCl3): d = 112.9 (d, JPRh = 243 Hz).
In a Schlenk flask [RhCl(COD)]2 (0.060 g, 0.122 mmol) was dis-
solved in CH2Cl2 (2 mL). A solution of (rac)-6 (0.091 g, 0.244 mmol)
in CH2Cl2 (3 mL) was added to the solution of the metal precursor
with stirring and the solution was stirred for 1 h. The solution was
concentrated to about 1 mL. Pentane (5 mL) was added to the solu-
tion to precipitate the complex. The suspension was stirred for
10ꢀ15 min at 0 °C, the mother liquor was decanted and the resid-
ual solid was washed with pentane (5 mL). The solid was dried un-
der high vacuum for 2 days at 40 °C to give the complex (rac)-13 as
4.2.15. [IrCl(COD)(7a)], (15)
In a Schlenk flask [IrCl(COD)]2 (0.037 g, 0.055 mmol) was dis-
solved in THF (2 mL) and the ligand 7a (0.062 g, 0.122 mmol)
was added with stirring. The orange solution was stirred for 18 h.
The solvent was removed, and the residue washed with pentane
(2 ꢁ 3 mL). The solid was taken up in THF (2 mL), layered with pen-
tane and stored at ꢀ18 °C overnight. The solvent was decanted and
the solid was dried under high vacuum for 1 day to give the com-
plex 15 as a orange solid (0.060 g, 0.071 mmol, 58%). HRMS calcd
for C36H40NO2PS2193Ir, 806.1867; found, 806.1865 (FAB+, corre-
sponds to [Ir(COD)(7a)]). MS (FAB, 4-NBA, m/z) [36] 841 ([15]+,
5%), 806 ([15ꢀCl]+, 20%), 702 ([15ꢀSC6H4OCH3]+, 20%), 366
a
yellow solid (0.033 g, 0.053 mmol, 22%). Calcd for
C28H36ClNPRhS2: C, 54.24; H, 5.85. Found: C, 51.63; H, 5.67 [28].
HRMS calcd for C28H36NPRhS2, 584.1082; found, 584.1098 (FAB+,
corresponds to [Rh(COD){rac-(6b)}). MS (FAB, 4-NBA, m/z) [36]
619 ([13]+, 3%), 584 ([13ꢀCl]+, 100%), 511 ([13ꢀCOD]+, 80%), 476
([13ꢀClꢀCOD]+, 45%); IR (cmꢀ1, neat solid) 1978(s), 1494(s),
1450(s).
([7aꢀSC6H4OCH3]+, 100%); IR (cmꢀ1
,
neat solid) 3056(w),
2997(w), 2939(w), 2879(w), 2823(w), 1586(s), 1488(s), 1244(s).
1H NMR (CDCl3): d = 7.48ꢀ7.45 (d, JHH = 8.7 Hz, 4H, aromatic),
7.31–7.22 (m, 10H, aromatic), 6.73 (d, JHH = 8.4 Hz, 4H, aromatic),
5.23 (broad s, 2H, @CH), 4.09 (d, J = 12.5 Hz, 4H, 2NCH2), 3.77 (s,
6H, 2CH3), 3.36 (broad s, 2H, 2 = CH), 2.04–2.00 (m, 4H, 2CH2),
1.77–1.61 (m, 4H, 2CH2); 13C{1H} NMR (CDCl3): d = 160.6 (d,
JCP = 2.4 Hz), 138.5 (d, JCP = 3.2 Hz), 137.1 (d, JCP = 2.0 Hz), 129.1
(s), 128.3 (s), 127.4 (s), 118.7 (s), 114.4 (d, JCP = 1.4 Hz, aromatic),
97.6 (d, JCP = 16.5 Hz, @CH), 55.7 (d, JCP = 5.3 Hz), 53.1 (d,
JCP = 6.2 Hz), 33.3 (d, JCP = 3.5 Hz, CH2), 29.1 (d, JCP = 2.6 Hz, CH2);
31P{1H} NMR (CDCl3): d = 108.5 (s).
1H NMR (CDCl3): d = 7.53ꢀ7.24 (m, 10H, 2Ph), 5.52 (broad s, 2H,
2 = CH), 5.06ꢀ4.97 (m, 2H, NCH2), 4.48ꢀ4.38 (m, 2H, NCH2), 3.82 (s,
1H, @CH), 3.72 (s, 1H, @CH), 3.41ꢀ3.33 (m, 1H, CHS), 3.25ꢀ3.17 (m,
1H, CHS0), 2.45ꢀ2.39 (m, 2H, CH2), 2.27ꢀ2.02 (m, 8H, 4CH2),
1.88ꢀ1.19 (m, 6H, 3CH2); 13C{1H} NMR (CDCl3): d = 137.7 (d,
J = 2.3 Hz), 129.2 (s), 128.9 (s), 128.7 (s), 128.4 (s), 128.1 (s),
127.3 (s, aromatic), 107.2 (dd, J = 13.6 Hz, J = 7.1 Hz, @CH), 106.6
(dd, J = 15.0 Hz, J = 6.2 Hz, @CH), 75.4 (d, J = 14.0 Hz, @CH), 71.8
(d, J = 13.0 Hz, @CH), 61.7 (d, J = 3.4 Hz), 59.6 (d, J = 2.7 Hz), 53.2
(d, J = 9.5 Hz), 33.3 (d, J = 3.2 Hz), 32.6 (d, J = 3.3 Hz), 29.0 (s), 28.2
(s), 25.8 (d, J = 15.4 Hz); 31P{1H} NMR (CDCl3): d = 127.3 (d,
1JPRh = 194 Hz).
4.2.16. [RhCl(COD)(4)], (16)
Complex 16 was synthesized from [RhCl(COD)]2 (0.050 g,
0.101 mmol) and the ligand 4 (0.064 g, 0.202 mmol) as described
above for rac-13. Complex 16 was isolated as a yellow brown solid
(0.107 g, 0.189 mmol, 93%). Calcd for C24H30ClNPRhS2: C, 50.93; H,
5.34. Found: C, 49.61; H, 5.20 [28]. HRMS calcd for C24H30NPRhS2,
530.0612; found, 530.0605 (FAB+, corresponds to [Rh(COD)(4)]).
MS (FAB, 4-NBA, m/z) [36] 565 ([16]+, 5%), 530 ([16ꢀCl]+, 55%),
457 ([16ꢀCOD]+, 40%), 422 ([16ꢀClꢀCOD]+, 18%).
4.2.13. [RhCl(COD)(7a)], (14a)
Complex 14a was synthesized from [RhCl(COD)]2 (0.050 g,
0.101 mmol) and ligand 7a (0.103 g, 0.204 mmol) as described
above for rac-13. Complex 14a was isolated as a yellow solid
(0.128 g, 0.171 mmol, 84%). Calcd for
C36H40ClNO2PRhS2: C,
57.48; H, 5.36. Found: C, 57.37; H, 5.33. HRMS calcd for
C
36H40NO2PRhS2, 716.1293; found, 716.1272 (FAB+, corresponds
1H NMR (CDCl3): d = 7.37ꢀ7.24 (m, 10H, aromatic), 5.53 (broad
s, 2H, 2 = CH), 4.69 (d, J = 12.1 Hz, 4H, 2NCH2), 3.81 (broad s, 2H,
2 = CH), 3.55–3.46 (m, 2H, 2SCHH0), 3.32–3.25 (m, 2H, 2SCHH0),
2.39–2.25 (m, 4H, 2CH2), 2.11–2.05 (m, 4H, 2CH2); 13C{1H} NMR
(CDCl3): d = 137.8 (d, J = 2.5 Hz), 129.1 (s), 128.9 (s), 128.2 (s),
127.6 (s, aromatic), 107.2 (dd, J = 6.8 Hz, J = 14.9 Hz, @CH), 73.8
(d, J = 13.4 Hz, @CH), 53.4 (d, J = 9.3 Hz), 41.3 (d, J = 3.3 Hz), 34.5
(s), 33.2 (d, J = 2.8 Hz), 29.2 (s), 28.4 (s), 22.8 (s); 31P{1H} NMR
to [Rh(COD)(7a)]). MS (FAB, 4-NBA, m/z) [36] 716 ([14aꢀCl]+,
20%), 612 ([14aꢀClꢀSC6H4OCH3]+, 15%).
1H NMR (CDCl3): d = 7.63 (d, JHH = 8.0 Hz, 4H, aromatic),
7.43ꢀ7.21 (m, 10H, aromatic), 6.88 (d, JHH = 8.7 Hz, 4H, aromatic),
5.59 (broad s, 2H, @CH), 4.29–4.25 (m, 4H, 2NCH2), 3.91–3.89 (m,
2H, 2 = CH), 3.84 (s, 6H, 2CH3), 2.26 (m, 4H, 2CH2), 1.99 (m, 4H,
2CH2); 13C{1H} NMR (CDCl3): d = 160.9 (s), 138.7 (s), 137.4 (s),
129.4 (s), 128.6 (s), 127.7 (s), 119.5 (s), 115.0 (s), 114.7 (s),
107.5ꢀ107.2 (m, @CH), 72.6–72.5 (m, @CH), 55.7 (s), 53.9–53.8
(m), 33.1 (s), 28.8 (s); 31P{1H} NMR (CDCl3): d = 133.1 (d,
1JPRh = 197 Hz).
1
(CDCl3): d = 139.1 (d, JPRh = 194 Hz).
*
4.2.17. [IrCl2Cp (7b)], (17b)
In a Schlenk flask [IrCl2Cp*]2 (0.050 g, 0.063 mmol) was dis-
solved in CH2Cl2 (2 mL). A solution of the phosphoramidite 7b
(0.060 g, 0.126 mmol) in CH2Cl2 (3 mL) was added to the solution
of the metal precursor with stirring and the solution was stirred
for 1 h. The solution was concentrated to nearly 1 mL and pentane
(10 mL) was added. A precipitate formed. The mixture was cooled
in an ice bath and the pentane layer was decanted. The solid was
dried under high vacuum for 2 days at 40 °C to give the complex
17b as a yellow solid (0.070 g, 0.080 mmol, 64%). Calcd for
4.2.14. [RhCl(COD)(7b)], (14b)
Complex 14b was synthesized from [RhCl(COD)]2 (0.026 g,
0.053 mmol) and phosphoramidite 7b (0.050 g, 0.106 mmol) as de-
scribed above for rac-13. Complex 14b was isolated as a yellow solid
(0.039 g, 0.054 mmol, 51%). Calcd for C36H40ClNPO4Rh: C, 60.05; H,
5.60. Found: C, 59.79; H, 5.51. HRMS calcd for C36H40 NPO4Rh,
684.1750; found, 684.1757 (FAB+, corresponds to [RhCl(COD)(7b)]).
MS (FAB, Peg 600/900, NaI, m/z) [36] 684 ([14bꢀCl]+, 25%), 611
([14bꢀCOD]+, 100%), 575 ([14bꢀCODꢀCl]+, 45%).
C
38H43Cl2IrNO4P: C, 52.35; H, 4.97. Found: C, 50.39; H, 4.82 [28].
HRMS calcd for C38H4335Cl193IrNO4P, 836.2247; found, 836.2254